PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress

Author:

Chavez James S.1ORCID,Rabe Jennifer L.1ORCID,Loeffler Dirk2ORCID,Higa Kelly C.3ORCID,Hernandez Giovanny1ORCID,Mills Taylor S.14ORCID,Ahmed Nouraiz2ORCID,Gessner Rachel L.1ORCID,Ke Zhonghe1ORCID,Idler Beau M.1ORCID,Niño Katia E.1ORCID,Kim Hyunmin5ORCID,Myers Jason R.6ORCID,Stevens Brett M.1ORCID,Davizon-Castillo Pavel7ORCID,Jordan Craig T.1ORCID,Nakajima Hideaki8ORCID,Ashton John6ORCID,Welner Robert S.9ORCID,Schroeder Timm2ORCID,DeGregori James1347ORCID,Pietras Eric M.14ORCID

Affiliation:

1. Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO

2. Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Basel, Switzerland

3. Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO

4. Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO

5. Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO

6. Genomics Research Center, University of Rochester, Rochester, NY

7. Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO

8. Department of Stem Cell and Immune Regulation, Yokohama City University School of Medicine, Yokohama, Japan

9. Division of Hematology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Abstract

Hematopoietic stem cells (HSCs) are capable of entering the cell cycle to replenish the blood system in response to inflammatory cues; however, excessive proliferation in response to chronic inflammation can lead to either HSC attrition or expansion. The mechanism(s) that limit HSC proliferation and expansion triggered by inflammatory signals are poorly defined. Here, we show that long-term HSCs (HSCLT) rapidly repress protein synthesis and cell cycle genes following treatment with the proinflammatory cytokine interleukin (IL)-1. This gene program is associated with activation of the transcription factor PU.1 and direct PU.1 binding at repressed target genes. Notably, PU.1 is required to repress cell cycle and protein synthesis genes, and IL-1 exposure triggers aberrant protein synthesis and cell cycle activity in PU.1-deficient HSCs. These features are associated with expansion of phenotypic PU.1-deficient HSCs. Thus, we identify a PU.1-dependent mechanism triggered by innate immune stimulation that limits HSC proliferation and pool size. These findings provide insight into how HSCs maintain homeostasis during inflammatory stress.

Funder

National Institutes of Health

Boettcher Webb-Waring Early Career Investigator Award

Cleo Meador and George Ryland Scott Endowed Chair in Hematology

Swiss National Science Foundation

National Science Foundation

University of Colorado Cancer Center

National Cancer Institute

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3